Unknown

Dataset Information

Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.


ABSTRACT:

Importance

The US Department of Health and Human Services (HHS) has proposed to reform drug pricing in Medicare Part B, which primarily covers physician-administered drugs and biologic agents. One HHS proposal would shift coverage of certain drugs from Medicare Part B to Part D, which is administered by private prescription drug plans.

Objective

To estimate the association of changes of a shift in Medicare Part B to Part D with total drug spending and patient cost-sharing.

Design, setting, and participants

Retrospective drug cohort study of the 75 brand-name drugs associated with the highest Part B expenditures among fee-for-service Medicare beneficiaries in 2016.

Main outcomes and measures

Estimated total Medicare spending in Part B and Part D; annual out-of-p

SUBMITTER: Hwang TJ 

PROVIDER: S-EPMC6439690 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature